会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • PROCESS FOR THE PREPARATION OF SUBSTITUTED N-(5-BENZENESULFONYL-1H-INDAZOL-3-YL)-BENZAMIDES
    • 制备取代的N-(5-苯并呋喃-1H-吲哚-3-基) - 苯甲酸的方法
    • WO2015110467A1
    • 2015-07-30
    • PCT/EP2015/051133
    • 2015-01-21
    • NERVIANO MEDICAL SCIENCES S.R.L.
    • ARCARI, AlessandroD'ARASMO, GermanoLOMBARDI BORGIA, Andrea
    • C07D405/14C07D231/56C07D405/12
    • C07D231/56C07D405/12C07D405/14
    • The present invention relates to a process for the preparation of substituted N-(5-benzenesulfonyl-1 H-indazol-3-yl)-benzamides and to the useful intermediate compounds of such process. Such derivatives are described and claimed in WO2008/074749, which also discloses processes for their preparation. The process of the present invention allows to obtain the desired products in high yields and purity and with a limited number of steps. The synthesis starts from 5-iodo-1 H-indazol-3-ylamine and comprises, as the key steps, the coupling of an activated benzoic acid with a 5-phenylsulfanyl-1 H-indazol-3-ylamine scaffold and the subsequent oxidation of the sulfur atom, followed by further functional group transformations, which furnish the desired products. The compounds prepared according to the process of the present invention are endowed with protein kinase inhibiting activity and, more particularly, IGF-1R or ALK inhibiting activity. The compounds are therefore useful in the treatment of a variety of cancers, cell proliferative disorders and diseases associated with protein kinases.
    • 本发明涉及制备取代的N-(5-苯磺酰基-1H-吲唑-3-基) - 苯甲酰胺的方法和该方法的有用的中间体化合物。 在WO2008 / 074749中描述和要求保护这些衍生物,其也公开了它们的制备方法。 本发明的方法允许以高产率和纯度和有限数量的步骤获得所需的产物。 合成从5-碘-1H-吲唑-3-基胺开始,并且作为关键步骤包括活化的苯甲酸与5-苯基硫烷基-1H-吲唑-3-基胺支架的偶联和随后的氧化 的硫原子,随后进一步的官能团转化,其提供所需的产物。 根据本发明的方法制备的化合物具有蛋白激酶抑制活性,更具体地,赋予IGF-1R或ALK抑制活性。 因此,这些化合物可用于治疗多种癌症,细胞增殖性疾病和与蛋白激酶相关的疾病。
    • 9. 发明申请
    • 6,7- DIHYDROIMIDAZO [1,5-A] PYRAZIN-8 (5H) - ONE DERIVATIVES AS PROTEIN KINASE MODULATORS
    • 6,7-二氢吲哚并[1,5-A]吡嗪-8(5H) - 一种衍生物作为蛋白激酶调节剂
    • WO2011092120A1
    • 2011-08-04
    • PCT/EP2011/050846
    • 2011-01-21
    • NERVIANO MEDICAL SCIENCES S.r.l.MIRIZZI, DaniloORRENIUS, Sten ChristianTRIFIRO', Paolo
    • MIRIZZI, DaniloORRENIUS, Sten ChristianTRIFIRO', Paolo
    • C07D487/04A61K31/4985A61P35/00
    • C07D487/04
    • There are provided 3,5-disubstituted derivatives of 6,7-dihydroimidazo[1,5-a]pyrazin-8(5H)-one compounds of formula (I) or a pharmaceutically acceptable salt thereof as defined in the present specification, which modulate the activity of protein kinases. The compounds are therefore useful in treating diseases caused by dysregulated protein kinase activity. In particular, such diseases to be treated with a compound of formula (I) of the present invention is one caused by and/or associated with disregulated protein kinase activity selected from the group consisting of cancer, viral infection, prevention of AIDS development in HIV-infected individuals, cell proliferative disorders, autoimmune and neurodegenerative disorders. The present invention also relates to processes for preparing the compounds of formula (I), combinatorial libraries thereof, pharmaceutical compositions comprising them, and methods of treating diseases utilizing pharmaceutical compositions comprising a compound of formula (I).
    • 提供了本说明书中定义的式(I)的6,7-二氢咪唑并[1,5-a]吡嗪-8(5H) - 酮化合物或其药学上可接受的盐的3,5-二取代衍生物,其中 调节蛋白激酶的活性。 因此,这些化合物可用于治疗由失调的蛋白激酶活性引起的疾病。 特别地,用本发明的式(I)化合物治疗的这些疾病是由选自下组的失调的蛋白激酶活性引起的和/或与其相关的,所述蛋白激酶活性选自癌症,病毒感染,HIV预防艾滋病发展 感染的个体,细胞增殖性疾病,自身免疫和神经变性疾病。 本发明还涉及制备式(I)化合物的方法,其组合文库,包含它们的药物组合物,以及使用包含式(I)化合物的药物组合物治疗疾病的方法。